Seat­tle Ge­net­ics CEO Clay Sie­gal­l's comp pack­age soars to $18.1M, ri­val­ing Big Phar­ma chiefs

Af­ter tak­ing share­hold­ers on some­thing of a roller coast­er ride last year, Seat­tle Ge­net­ics CEO Clay Sie­gall re­ward­ed him­self with a com­pen­sa­tion pack­age that swelled …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER